Biomarker for detecting thrombosis tendency patient
By detecting the methylation levels of F5.24.CpG.10 and Protein S.44.CpG.29-33 sites, the problem of early screening and diagnosis of thrombosis tendency was solved, and a high-accurate prediction of thrombosis risk was achieved. , provides a scientific basis for personalized prevention and management.
CN119120690APending Publication Date: 2024-12-13THE SECOND AFFILIATED HOSPITAL OF KUNMING MEDICAL UNIV (YUNNAN PROVINCIAL UROLOGY HOSPITAL YUNNAN PROVINCIAL HEPATOBILIARY & PANCREATIC SURGERY HOSPITAL)
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CN202411333215.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-24
- Publication Date
- 2024-12-13
Smart Images
Figure CN119120690A_ABST
Abstract
The invention provides a biomarker for detecting a thrombosis tendency patient, and belongs to the technical field of biomedicine, the biomarker comprises a CpG site of a target region, the target region comprises an F5 gene or / and a Protein S gene, the nucleotide sequence of the F5 gene is as shown in SEQ ID NO: 23, and the nucleotide sequence of the Protein S gene is as shown in SEQ ID NO: 17. The invention is of great significance to early screening and clinical intervention of thrombus and guidance of patient treatment.
Need to check novelty before this filing date? Find Prior Art